3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Breast Neoplasms
16
Carcinoma, Intraductal, Noninfiltrating
5
Breast Carcinoma In Situ
4
Neoplasms
2
Infertility
2
Breast Diseases
2
Uterine Cervical Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Polycystic Ovary Syndrome
1
Pancreatic Cyst
1
Ovarian Neoplasms
1
Neoplasms by Site
1
Hereditary Sensory and Autonomic Neuropathies
1
Head and Neck Neoplasms
1
Endometrial Neoplasms
1
Breast Neoplasms, Male
1
Anovulation
1
Interventions
Metformin
5
Letrozole
3
Inositol
2
Clomiphene
2
mirabegron
1
maltodextrin
1
dapagliflozin
1
Tamoxifen
1
Surveys and Questionnaires
1
Positron-Emission Tomography
1
Pioglitazone
1
Pharmaceutical Preparations
1
Hydroquinones
1
Diet, Ketogenic
1
Contraceptives, Oral
1
Ascorbic Acid
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Polycystic Ovary Syndrome
×
Tamoxifen
×
30 days
×
Clear all
NCT07616973
2026-06-01
LET-CC-TAM
Sana'a University
Phase 3
Active not recruiting
240 enrolled